The discrepancy between the tumorsphere forming assay and the total number of ALDH+ cells prompted us to determine whether the subtypes of tumorspheres would respond differently to chemotherapy, as we have previously observed in HNSCC, and if differential responses would be due to CSCs with distinct behavior and ability to respond to chemotherapy. The gene discussed is LDHA; the disease is head and neck squamous cell carcinoma.